Literature DB >> 21735750

[A case of imatinib mesylate-induced pneumonitis based on the detection of epithelioid granulomas by video-assisted thoracoscopic surgery biopsy in a patient with chronic myeloid leukemia].

Takashi Koide1, Takeshi Saraya, Keitaro Nakamoto, Akira Nakajima, Haruyuki Ishii, Masachika Fujiwara, Hidekatsu Shibata, Teruaki Oka, Tomoyuki Goya, Hajime Goto.   

Abstract

A 79-year-old man with chronic myeloid leukemia was referred to our department because of dry cough and low-grade fever, 272 days after commencing imatinib mesylate (Gleevec). High resolution computed tomography (HRCT) showed tiny scattered centrilobular nodules and ground-glass opacities throughout both lung fields, suggesting drug-induced pneumonitis. A thoracic video-assisted thoracoscopic surgery (VATS) biopsy specimen from the centrilobular nodules in the right upper lobe demonstrated patchy distribution of epithelioid cell granulomas and intra-alveolar organization. Most of those lesions were predominantly located in the alveolar spaces, which implicated non-transbronchial distribution. Following drug cessation alone, the patient's general condition and radiological abnormalities improved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21735750

Source DB:  PubMed          Journal:  Nihon Kokyuki Gakkai Zasshi        ISSN: 1343-3490


  3 in total

1.  High-resolution computed tomography findings for patients with drug-induced pulmonary toxicity, with special reference to hypersensitivity pneumonitis-like patterns in gemcitabine-induced cases.

Authors:  Masaki Tamura; Takeshi Saraya; Masachika Fujiwara; Sayuki Hiraoka; Takuma Yokoyama; Kinuko Yano; Haruyuki Ishii; Junji Furuse; Tomoyuki Goya; Hajime Takizawa; Hajime Goto
Journal:  Oncologist       Date:  2013-02-12

2.  A case of imatinib-related obstructive bronchiolitis followed long term.

Authors:  Chika Yajima; Nariaki Kokuho; Kazutoshi Toriyama; Junichiro Kawagoe; Yuki Togashi; Jun Matsubayashi; Hideaki Nakayama; Yasuhiro Setoguchi; Shinji Abe
Journal:  Respir Med Case Rep       Date:  2020-04-04

3.  Development of imatinibmesylate-induced interstitial lung disease 2 weeks after discontinuation of the treatment: a case report.

Authors:  Shota Nakashima; Tomoyuki Kakugawa; Hiroko Motomura; Katsuji Hirano; Eisuke Sasaki; Yasuhiro Nagata; Akitoshi Kinoshita; Noriho Sakamoto; Yuji Ishimatsu; Hiroshi Mukae; Shigeru Kohno
Journal:  Multidiscip Respir Med       Date:  2012-11-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.